Professor Dame Louise Robinson discusses her Lancet Primary Care Viewpoint regarding primary care perspectives on the new therapeutic era for Alzheimer’s disease, including implications for the health-care workforce, the potential for use around the work, and useful data that are currently lacking.

Click here to read the full paper: https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(25)00061-5/fulltext

Follow us today at...

https://bsky.app/profile/lancetprimarycare.bsky.social

https://www.linkedin.com/company/the-lancet

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör The Lancet Group. Innehållet i podden är skapat av The Lancet Group och inte av, eller tillsammans med, Poddtoppen.